Irvin Mark Modlin

Irvin Mark Modlin's AcademicInfluence.com Rankings

Irvin Mark Modlin

Philosophy

#7107

World Rank

#10268

Historical Rank

Logic

#4182

World Rank

#5442

Historical Rank

philosophy Degrees

Download Badge

Philosophy

Irvin Mark Modlin's Degrees

Doctorate Medicine University of California, San Francisco
PhD Physiology University of California, San Francisco

Why Is Irvin Mark Modlin Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Irvin Mark Modlin's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

A 5‐decade analysis of 13,715 carcinoid tumors (2003) (2571)
Gastroenteropancreatic neuroendocrine tumours. (2008) (1504)
An analysis of 8305 cases of carcinoid tumors (2000) (1213)
Current status of gastrointestinal carcinoids. (2005) (802)
The epidemiology of gastroenteropancreatic neuroendocrine tumors. (2011) (745)
American Gastroenterological Association Medical Position Statement on the management of gastroesophageal reflux disease. (2008) (667)
Somatic c-KIT activating mutation in urticaria pigmentosa and aggressive mastocytosis: establishment of clonality in a human mast cell neoplasm (1996) (595)
Bronchopulmonary neuroendocrine tumors (2008) (462)
Neuroendocrine tumor epidemiology (2008) (391)
Recommendations for management of patients with neuroendocrine liver metastases. (2014) (391)
Review article: somatostatin analogues in the treatment of gastroenteropancreatic neuroendocrine (carcinoid) tumours (2009) (371)
Chromogranin A—Biological Function and Clinical Utility in Neuro Endocrine Tumor Disease (2010) (357)
Long-term tolerability of PRRT in 807 patients with neuroendocrine tumours: the value and limitations of clinical factors (2014) (316)
A 50-Year Analysis of 562 Gastric Carcinoids: Small Tumor or Larger Problem? (2004) (219)
Luminal regulation of normal and neoplastic human EC cell serotonin release is mediated by bile salts, amines, tastants, and olfactants. (2008) (217)
Gastric carcinoid tumors: the biology and therapy of an enigmatic and controversial lesion. (1995) (214)
Priorities for improving the management of gastroenteropancreatic neuroendocrine tumors. (2008) (210)
Consensus on biomarkers for neuroendocrine tumour disease. (2015) (203)
Objective Quantification of the Ki67 Proliferative Index in Neuroendocrine Tumors of the Gastroenteropancreatic System: A Comparison of Digital Image Analysis With Manual Methods (2012) (201)
Helicobacter pylori alters gastric epithelial cell cycle events and gastrin secretion in Mongolian gerbils. (2000) (188)
The molecular genetics of gastroenteropancreatic neuroendocrine tumors (2005) (177)
Approaches to the diagnosis of gut neuroendocrine tumors: the last word (today). (1997) (170)
The clinical relevance of chromogranin A as a biomarker for gastroenteropancreatic neuroendocrine tumors. (2011) (163)
Neuroendocrine tumors of the diffuse neuroendocrine system (2008) (163)
Neuroendocrine Tumors of the Gallbladder: An Evaluation and Reassessment of Management Strategy (2010) (148)
Neuroendocrine tumor disease: an evolving landscape. (2012) (147)
Therapeutic options for gastrointestinal carcinoids. (2006) (144)
The diversity and commonalities of gastroenteropancreatic neuroendocrine tumors (2011) (141)
The Identification of Gut Neuroendocrine Tumor Disease by Multiple Synchronous Transcript Analysis in Blood (2013) (140)
A precision oncology approach to the pharmacological targeting of mechanistic dependencies in neuroendocrine tumors (2018) (133)
The gastric enterochromaffin-like cell: an enigmatic cellular link. (1996) (120)
The Role of Genetic Markers— NAP1L1, MAGE-D2, and MTA1—in Defining Small-Intestinal Carcinoid Neoplasia (2006) (115)
IL1β‐ and LPS‐induced serotonin secretion is increased in EC cells derived from Crohn’s disease (2009) (113)
Siegfried Oberndorfer: origins and perspectives of carcinoid tumors. (2004) (109)
The functional characterization of normal and neoplastic human enterochromaffin cells. (2006) (105)
Measurement of circulating transcripts and gene cluster analysis predicts and defines therapeutic efficacy of peptide receptor radionuclide therapy (PRRT) in neuroendocrine tumors (2016) (102)
Gastrointestinal Carcinoids: The Evolution of Diagnostic Strategies (2006) (101)
Circulating Transcript Analysis (NETest) in GEP-NETs Treated With Somatostatin Analogs Defines Therapy. (2015) (101)
Uncommon cancers of the small intestine, appendix and colon: an analysis of SEER 1973-2004, and current diagnosis and therapy. (2008) (99)
Gastrointestinal neuroendocrine (carcinoid) tumours: current diagnosis and management (2010) (97)
The Status of Neuroendocrine Tumor Imaging: From Darkness to Light? (2014) (95)
Carcinoid tumors of the stomach. (2003) (94)
A multianalyte PCR blood test outperforms single analyte ELISAs (chromogranin A, pancreastatin, neurokinin A) for neuroendocrine tumor detection. (2014) (91)
Surgical Treatment of Achalasia: Current Status and Controversies (2004) (87)
PRRT genomic signature in blood for prediction of 177Lu-octreotate efficacy (2018) (86)
Carcinoid heart disease. (2008) (83)
Radiolabeled Somatostatin Analogue Therapy Of Gastroenteropancreatic Cancer. (2016) (83)
A Delphic consensus assessment: imaging and biomarkers in gastroenteropancreatic neuroendocrine tumor disease management (2016) (80)
Neuroendocrine tumor biomarkers: From monoanalytes to transcripts and algorithms. (2016) (80)
A Nomogram to Assess Small-Intestinal Neuroendocrine Tumor (‘Carcinoid’) Survival (2010) (80)
Blood and tissue neuroendocrine tumor gene cluster analysis correlate, define hallmarks and predict disease status. (2015) (79)
NET Blood Transcript Analysis Defines the Crossing of the Clinical Rubicon: When Stable Disease Becomes Progressive (2016) (79)
Limitations in small intestinal neuroendocrine tumor therapy by mTor kinase inhibition reflect growth factor–mediated PI3K feedback loop activation via ERK1/2 and AKT (2011) (78)
Microsatellite instability and gene mutations in transforming growth factor‐beta type II receptor are absent in small bowel carcinoid tumors (2005) (77)
Neuroendocrine Tumor Biomarkers: Current Status and Perspectives (2014) (76)
The NETest: The Clinical Utility of Multigene Blood Analysis in the Diagnosis and Management of Neuroendocrine Tumors. (2018) (75)
The Clinical Utility of a Novel Blood-Based Multi-Transcriptome Assay for the Diagnosis of Neuroendocrine Tumors of the Gastrointestinal Tract (2015) (74)
Advanced rectal cancer (1988) (71)
CTGF, intestinal stellate cells and carcinoid fibrogenesis. (2007) (70)
Use of an isotopic somatostatin receptor probe to image gut endocrine tumors. (1995) (70)
Current Concepts in 68Ga-DOTATATE Imaging of Neuroendocrine Neoplasms: Interpretation, Biodistribution, Dosimetry, and Molecular Strategies (2017) (69)
GeneChip, geNorm, and gastrointestinal tumors: novel reference genes for real-time PCR. (2007) (69)
Management of unresectable malignant endocrine tumors of the pancreas. (1993) (65)
Blood measurement of neuroendocrine gene transcripts defines the effectiveness of operative resection and ablation strategies. (2016) (64)
The 5‐HT2B receptor plays a key regulatory role in both neuroendocrine tumor cell proliferation and the modulation of the fibroblast component of the neoplastic microenvironment (2010) (63)
Neurohormonal modulation of rat enterochromaffin-like cell histamine secretion. (1996) (59)
Helicobacter pylori lipopolysaccharide stimulates histamine release and DNA synthesis in rat enterochromaffin-like cells. (1997) (59)
Molecular mechanisms in therapy of acid-related diseases (2007) (58)
A Novel Enterohepatic Helicobacter Species ‘Helicobacter mastomyrinus’ Isolated from the Liver and Intestine of Rodents (2005) (58)
Chromogranin A: any relevance in neuroendocrine tumors? (2016) (57)
Gastric carcinoids. The Yale Experience. (1995) (57)
Predicting neuroendocrine tumor (carcinoid) neoplasia using gene expression profiling and supervised machine learning (2009) (56)
Biological relevance of pituitary adenylate cyclase-activating polypeptide (PACAP) in the gastrointestinal tract (1999) (56)
Genetic Differentiation of Appendiceal Tumor Malignancy: A Guide for the Perplexed (2006) (56)
Differential cytotoxicity of novel somatostatin and dopamine chimeric compounds on bronchopulmonary and small intestinal neuroendocrine tumor cell lines (2008) (55)
Evolution of the Diffuse Neuroendocrine System – Clear Cells and Cloudy Origins (2006) (55)
A Comprehensive Assessment of the Role of miRNAs as Biomarkers in Gastroenteropancreatic Neuroendocrine Tumors (2018) (55)
PRRT neuroendocrine tumor response monitored using circulating transcript analysis: the NETest (2019) (52)
Helicobacter pylori lipopolysaccharide stimulates gastric mucosal pepsinogen secretion (1992) (52)
Neuroendocrine Neoplasms of the Small Bowel and Pancreas (2019) (52)
The role of mechanical forces and adenosine in the regulation of intestinal enterochromaffin cell serotonin secretion. (2012) (51)
Peptide receptor radionuclide therapy for advanced neuroendocrine tumors. (2014) (50)
Autoregulatory effects of serotonin on proliferation and signaling pathways in lung and small intestine neuroendocrine tumor cell lines (2009) (48)
Further delineation of the continuous human neoplastic enterochromaffin cell line, KRJ-I, and the inhibitory effects of lanreotide and rapamycin. (2007) (48)
Small bowel carcinoid (enterochromaffin cell) neoplasia exhibits transforming growth factor–β1‐mediated regulatory abnormalities including up‐regulation of C‐Myc and MTA1 (2007) (47)
Isolation, functional characterization, and transcriptome of Mastomys ileal enterochromaffin cells. (2006) (46)
Pituitary adenylate cyclase-activating polypeptide modulates gastric enterochromaffin-like cell proliferation in rats. (1999) (46)
KRJ-I and BON Cell Lines: Defining an Appropriate Enterochromaffin Cell Neuroendocrine Tumor Model (2009) (45)
Towards a new classification of gastroenteropancreatic neuroendocrine neoplasms (2016) (45)
Gut neuroendocrine tumor blood qPCR fingerprint assay: characteristics and reproducibility (2013) (45)
A mechanistic role for the chromatin modulator, NAP1L1, in pancreatic neuroendocrine neoplasm proliferation and metastases (2014) (44)
From the lumen to the laparoscope. (2004) (44)
The CCK2 receptor antagonist, YF476, inhibits Mastomys ECL cell hyperplasia and gastric carcinoid tumor development (2010) (43)
Gene transcript analysis blood values correlate with 68Ga-DOTA-somatostatin analog (SSA) PET/CT imaging in neuroendocrine tumors and can define disease status (2015) (43)
The role of transforming growth factor alpha in the enterochromaffin-like cell tumor autonomy in an African rodent mastomys. (1996) (42)
Follow-Up of Exocrine Pancreatic Function in Type-1 Diabetes mellitus (2005) (41)
Pharmacotherapy of neuroendocrine cancers. (2008) (40)
Acute Pancreatitis: A Historical Perspective (2009) (39)
Blood measurement of neuroendocrine gene transcripts defines the effectiveness of operative resection and ablation strategies (2016) (39)
A PCR blood test outperforms chromogranin A in carcinoid detection and is unaffected by proton pump inhibitors (2014) (39)
Gastrin-dependent inhibitory effects of octreotide on the genesis of gastric ECLomas. (1992) (38)
Gastrin and the Enterochromaffin-Like Cell: An Acid Update (1998) (37)
Role of CCN2/CTGF in the proliferation of Mastomys enterochromaffin-like cells and gastric carcinoid development. (2007) (37)
A Clinical Perspective on Gastric Neuroendocrine Neoplasia (2011) (37)
Q RT-PCR Detection of Chromogranin A: A New Standard in the Identification of Neuroendocrine Tumor Disease (2006) (36)
Principal Component Analysis, Hierarchical Clustering, and Decision Tree Assessment of Plasma mRNA and Hormone Levels as an Early Detection Strategy for Small Intestinal Neuroendocrine (Carcinoid) Tumors (2009) (36)
Aspects on diagnosis and treatment of the foregut carcinoid syndrome. (1992) (36)
The utility of blood neuroendocrine gene transcript measurement in the diagnosis of bronchopulmonary neuroendocrine tumours and as a tool to evaluate surgical resection and disease progression† (2018) (36)
Utility of molecular genetic signatures in the delineation of gastric neoplasia (2006) (36)
Gastrin-Mediated Alterations in Gastric Epithelial Apoptosis and Proliferation in a Mastomys Rodent Model of Gastric Neoplasia (2000) (36)
Gastroesophageal reflux disease: then and now. (2004) (35)
Siegfried oberndorfer and the evolution of carcinoid disease. (2007) (35)
The archaic distinction between functioning and nonfunctioning neuroendocrine neoplasms is no longer clinically relevant (2011) (35)
Gene network-based analysis identifies two potential subtypes of small intestinal neuroendocrine tumors (2014) (35)
A 40-year analysis of 265 gastric carcinoids. (1997) (35)
Gene Network Inference and Biochemical Assessment Delineates GPCR Pathways and CREB Targets in Small Intestinal Neuroendocrine Neoplasia (2011) (35)
rab3D protein is a specific marker for zymogen granules in gastric chief cells of rats and rabbits. (1996) (34)
Gastric stem cells: an update. (2003) (34)
Delineation of the chemomechanosensory regulation of gastrin secretion using pure rodent G cells. (2009) (34)
Serotonin and the 5‐HT7 receptor: The link between hepatocytes, IGF‐1 and small intestinal neuroendocrine tumors (2013) (33)
Increasing incidence of cecal and sigmoid carcinoma: Data from the connecticut tumor registry (1990) (32)
Inhibition of proliferation of small intestinal and bronchopulmonary neuroendocrine cell lines by using peptide analogs targeting receptors (2008) (32)
From Prout to the proton pump--a history of the science of gastric acid secretion and the surgery of peptic ulcer. (1990) (32)
Systemic therapeutic options for carcinoid. (2013) (31)
Molecular profiling of neuroendocrine tumours to predict response and toxicity to peptide receptor radionuclide therapy. (2020) (31)
Decoding the Molecular and Mutational Ambiguities of Gastroenteropancreatic Neuroendocrine Neoplasm Pathobiology (2015) (30)
Biology and management of gastric carcinoid tumours: a review. (2002) (30)
Aspects of the theoretical basis and clinical relevance of low acid states. (1994) (30)
Measurement of circulating transcript levels (NETest) to detect disease recurrence and improve follow‐up after curative surgical resection of well‐differentiated pancreatic neuroendocrine tumors (2018) (30)
A comparison of the effects of gastrin, somatostatin and dopamine receptor ligands on rat gastric enterochromaffin-like cell secretion and proliferation (2007) (30)
A short history of neuroendocrine tumours and their peptide hormones. (2016) (29)
Gastric carcinoids (neuroendocrine neoplasms). (2013) (29)
Adenosine A2A and A2B receptor expression in neuroendocrine tumours: potential targets for therapy (2012) (29)
EGFR/TGFα and TGFβ/CTGF Signaling in Neuroendocrine Neoplasia: Theoretical Therapeutic Targets (2012) (28)
The clinical applications of a multigene liquid biopsy (NETest) in neuroendocrine tumors (2019) (28)
Acute Pancreatitis at Its Centenary: The Contribution of Reginald Fitz (1990) (28)
The mastomys gastric carcinoid: aspects of enterochromaffin-like cell function. (1994) (28)
Myeloid neoplasms after chemotherapy and PRRT: myth and reality. (2016) (27)
Telenzepine-sensitive muscarinic receptors on rat pancreatic acinar cells. (1998) (27)
Global expression analysis of ECL cells in Mastomys natalensis gastric mucosa identifies alterations in the AP-1 pathway induced by gastrin-mediated transformation. (2004) (27)
Differential signal pathway activation and 5-HT function: the role of gut enterochromaffin cells as oxygen sensors. (2012) (27)
Blood mRNA Measurement (NETest) for Neuroendocrine Tumor Diagnosis of Image-Negative Liver Metastatic Disease (2018) (27)
An Assessment of Circulating Chromogranin A as a Biomarker of Bronchopulmonary Neuroendocrine Neoplasia: A Systematic Review and Meta-Analysis (2019) (25)
Predicting the survival of patients with small bowel neuroendocrine tumours: comparison of 3 systems (2017) (25)
PACAP mediates the neural proliferative pathway of Mastomys Enterochromaffin-like cell transformation (2001) (24)
Cyclin D1 Antisense Oligonucleotide Inhibits Cell Growth Stimulated by Epidermal Growth Factor and Induces Apoptosis of Gastric Cancer Cells (2001) (24)
Chromogranin A and Its Fragments as Regulators of Small Intestinal Neuroendocrine Neoplasm Proliferation (2013) (24)
Identification of rab2 as a tubulovesicle-membrane-associated protein in rabbit gastric parietal cells. (1992) (23)
Endocrine tumors of the pancreas. (1979) (23)
The pivotal role of John S. Edkins in the discovery of gastrin (1997) (23)
A liquid biopsy for bronchopulmonary/lung carcinoid diagnosis (2015) (22)
Edkins and a Century of Acid Suppression (2005) (21)
Duodenal gastrinoma: the solution to the pancreatic paradox. (1994) (21)
A multitranscript blood neuroendocrine tumor molecular signature to identify treatment efficacy and disease progress. (2013) (21)
Stathmin in pancreatic neuroendocrine neoplasms: a marker of proliferation and PI3K signaling (2014) (20)
Early Identification of Residual Disease After Neuroendocrine Tumor Resection Using a Liquid Biopsy Multigenomic mRNA Signature (NETest) (2021) (20)
Historical perspectives on the treatment of gastroesophageal reflux disease. (2003) (20)
PRRT: Defining the Paradigm Shift to Achieve Standardization and Individualization (2014) (20)
Trefoil peptides: mitogens, motogens, or mirages? (1997) (19)
Evidence for a regulatory role for histamine in gastric enterochromaffin-like cell proliferation induced by hypergastrinemia. (1996) (19)
Autoregulation of enterochromaffin-like cell histamine secretion via the histamine 3 receptor subtype. (1996) (19)
Multiple gastrointestinal stromal tumors and synchronous ileal carcinoids (2005) (19)
From Leningrad to London: The Saga of Kulchitsky and the Legacy of the Enterochromaffin Cell (2008) (19)
Pathophysiology of the fundic enterochromaffin-like (ECL) cell and gastric carcinoid tumours. (1996) (18)
Rectal neuroendocrine tumors : Diagnosis and treatment (2007) (18)
Peptide Receptor Radionuclide Therapy of Neuroendocrine Tumors. (2015) (18)
The clinical utility of circulating neuroendocrine gene transcript analysis in well-differentiated paragangliomas and pheochromocytomas. (2017) (17)
Glucagon receptor gene mutations with hyperglucagonemia but without the glucagonoma syndrome. (2015) (17)
Friedrich Feyrter: A Precise Intellect in a Diffuse System (2006) (17)
The clinical implications and biologic relevance of neurofilament expression in gastroenteropancreatic neuroendocrine neoplasms (2012) (17)
Treatment of advanced gastroenteropancreatic neuroendocrine neoplasia, are we on the way to personalised medicine? (2021) (17)
Immunohistochemical evidence for an impairment of autophagy in tumorigenesis of gastric carcinoids and adenocarcinomas in rodent models and patients. (2013) (17)
Gastrin and colorectal cancer (1992) (17)
Somatostatin receptor regulation of gastric enterochromaffin-like cell transformation to gastric carcinoid. (1996) (16)
Utility of a ready-to-use PCR system for neuroendocrine tumor diagnosis (2019) (15)
Primary Carcinoid Tumor of the Parotid Gland: A Case Report and Review of the Literature (2006) (15)
Ernest Starling and the discovery of secretin. (2001) (15)
Screening for colorectal neoplasms (1987) (15)
Microencapsulation of small intestinal neuroendocrine neoplasm cells for tumor model studies (2012) (14)
Improving the Diagnosis and Management of Neuroendocrine Tumors: Utilizing New Advances in Biomarker and Molecular Imaging Science (2013) (14)
New pharmacologic therapies for gastroenteropancreatic neuroendocrine tumors. (2010) (14)
Parietal cell activation by arborization of ECL cell cytoplasmic projections is likely the mechanism for histamine induced secretion of hydrochloric acid (2011) (14)
Blood transcript analysis and metastatic recurrent small bowel carcinoid management (2014) (14)
The role of peptide receptor radionuclide therapy in advanced/metastatic thoracic neuroendocrine tumors. (2017) (14)
Therapy: The role of liquid biopsies to manage and predict PRRT for NETs (2017) (13)
Helicobacter pylori Lipopolysaccharide Alters ECL Cell DNA Synthesis via a CD14 Receptor and Polyamine Pathway in Mastomys (2000) (13)
Enterochromaffin-like cells and gastric argyrophil carcinoidosis. (1991) (13)
A Multigenomic Liquid Biopsy Biomarker for Neuroendocrine Tumor Disease outperforms CgA and has Surgical and Clinical Utility. (2021) (13)
Adrenergic and cromolyn sodium modulation of ECL cell histamine secretion. (1995) (13)
Van Swieten and the Renaissance of the Vienna Medical School (2001) (13)
Surgery for Obesity: Panacea or Pandora’s Box? (2006) (12)
Genotoxicity, carcinogenicity and acid-suppressing medications. (1995) (12)
Symptom Evaluation in Gastroesophageal Reflux Disease (2008) (11)
GERD Evaluation: Time for a New Paradigm? (2007) (11)
Caveat Emptor: Let Our Acclaim of the Apotheosis of PRRT Not Blind Us to the Error of Prometheus (2019) (11)
Frederik Ruysch: Master Anatomist and Depictor of the Surreality of Death (1999) (11)
Enterochromaffin‐like Cell Pathobiology of Mastomys (1994) (11)
Bayliss and Starling and the nascence of endocrinology (2000) (10)
Molecular strategies in the management of bronchopulmonary and thymic neuroendocrine neoplasms. (2017) (10)
Partial agonism by gastrin for a cholecystokinin receptor mediating pepsinogen secretion. (1993) (10)
A century of advances in neuroendocrine tumor biology and treatment : A tribute to Siegried Oberndorfer (2007) (10)
Small intestinal neuroendocrine cell pathobiology: ‘carcinoid’ tumors (2011) (10)
Neuroendocrine Tumor Omic Gene Cluster Analysis Amplifies the Prognostic Accuracy of the NETest (2020) (10)
Intra‐ocular transplantation of carcinoid tumours from Mastomys and humans (1990) (9)
Molecular Genomic Assessment Using a Blood-based mRNA Signature (NETest) is Cost-effective and Predicts Neuroendocrine Tumor Recurrence With 94% Accuracy (2021) (9)
Critical reappraisal of mucosal repair mechanisms. (1995) (9)
Blood Chromogranin A Is Not Effective as a Biomarker for Diagnosis or Management of Bronchopulmonary Neuroendocrine Tumors/Neoplasms (2019) (8)
GERD 2004: issues from the past and a consensus for the future. (2004) (8)
The future of nuclear medicine imaging of neuroendocrine tumors: on a clear day one might see forever… (2014) (8)
In situ RNA-RNA hybridisation of phospholipase C beta 3 shows lack of expression in neuroendocrine tumours. (2003) (8)
Gastrin-regulated expression of p53 in transformed enterochromaffin-like cells in the African rodent mastomys. (1998) (7)
Oddi: the paradox of the man and the sphincter. (1994) (7)
The Luminati of Leiden: From Bontius to Boerhaave (1999) (7)
A polyamine pathway-mediated mitogenic mechanism in enterochromaffin-like cells of Mastomys. (1998) (7)
Analysis of Cytotoxic Effects of Chemotherapeutic Agents on Lung and Small Intestinal Neuroendocrine Cell Lines (2008) (7)
Evolution of one-handed piano compositions. (2008) (7)
Manpower in gastroenterology in the United States: a position paper of the Training and Education Committee of the AGA. (1989) (7)
The Status of the Hiatus: The Role of Hernia in Gastroesophageal Reflux Disease (2007) (6)
[Gastrointestinal neuroendocrine tumors]. (2008) (6)
Minichromosome Maintenance Expression Defines Slow-Growing Gastroenteropancreatic Neuroendocrine Neoplasms1 (2016) (6)
Whither peptide receptor radionuclide therapy for neuroendocrine tumors: an Einsteinian view of the facts and myths (2014) (6)
A novel serine-specific kinase activity associated with exocrine secretory granules. (1995) (6)
GERD 2003: issues from the past and a consensus for the future. (2004) (6)
A new look at an old hormone gastrin (1993) (6)
Pituitary adenylate cyclase-activating peptide (PACAP) modulates gastric enterochromaffin-like (ECL) cell proliferation in rats (1998) (6)
GNA15 expression in small intestinal neuroendocrine neoplasia: functional and signalling pathway analyses. (2015) (6)
Regulation of mastomys ECL cell function by transforming growth factor alpha. (1996) (6)
Pepsinogen release and acid secretion from human and guinea pig gastric mucosa compromised by hypoxia, endotoxin, or critical illness. (1990) (5)
Somatostatin receptor regulation of gastric carcinoid tumours. (1996) (5)
A Sensitive, Portable Microfluidic Device for SARS-CoV-2 Detection from Self-Collected Saliva (2021) (5)
A combination of surgery, theranostics, and liquid biopsy - a personalised oncologic approach to treatment of patients with advanced metastatic neuroendocrine neoplasms (2021) (5)
Harvey Cushing: first guest at "The Divine Banquet of the Brayne". (1993) (5)
Of Fibiger and fables: a cautionary tale of cockroaches and Helicobacter pylori. (2001) (5)
Rudolf Schindler--a man for all seasons. (2000) (5)
Regnier de Graaf: Paris, purging, and the pancreas. (2000) (5)
A historical appreciation of bronchopulmonary neuroendocrine neoplasia: resolution of a carcinoid conundrum. (2014) (4)
A Novel Liquid Biopsy (NETest) identifies Paragangliomas and Pheochromocytomas with High Accuracy. (2021) (4)
The Use of Deep Learning and Neural Networks in Imaging: Welcome to the New Mathematical Milieu of Medicine (2019) (4)
Comparison of PCR-based detection of chromogranin A mRNA with traditional histological lymph node staging of small intestinal neuroendocrine neoplasia (2012) (4)
A brief historical perspective and a comparison of the current systems of surgical training in Great Britain, Germany and the United States of America. (1993) (4)
Costs of gerd: facts and fiction1 (2003) (4)
Glucagon receptor gene mutations with hyperglucagonemia but without the glucagonoma syndrome (2016) (3)
Information Assimilation and Distribution Challenges and Goals for Real and Virtual Journals (2005) (3)
Adaptation and renewal of the gastrointestinal surgeon to meet the continuous challenge of modern gastroenterology. (1992) (3)
The elucidation of peptic esophagitis: from Hamperl to heartburn. (2007) (3)
An Ileal Endometrioma: Of Carcinoids and Cadherin (2007) (3)
Diagnosis and management of gastrointestinal neuroendocrine tumors. (1993) (3)
To repair the fault or end the acid reign? (1995) (3)
CorrespondenceManpower in gastroenterology in the United States: A position paper of the training and education committee of the AGA* (1989) (3)
The transcriptional regulation of c-fos/ c-jun during PACAP stimulated ECL cell proliferation (2000) (3)
Gastric enterochromaffin-like (ECL) transformation is associated with increased expression of the G1 cell cycle regulators cyclin D1 and CDK4 (1998) (3)
Chronic Pancreatitis: A Precursor to Pancreatic Carcinoma? (1994) (3)
Surgery of chronic pancreatitis: Chronicle of confusion and despair (2002) (3)
Evolution of a operative strategy for diagnosis and management of duodenal gastrinomas. (1994) (3)
List of available training programs. (1973) (3)
Ultrastructure of ECL cells in Mastomys after long-term treatment with H2 receptor antagonist loxtidine (2012) (3)
Costs of gerd: facts and fiction. (2003) (3)
A Blood-Based Multi-Transcript Test - the NETest - Predicts and Defines the Efficacy of Peptide Radio Receptor Therapy in Neuroendocrine Tumors (2016) (3)
Antrectomy obviates gastric carcinoid formation even in a genetically predisposed model mastomys (1998) (2)
Circulating Biomarkers of GEP and Lung NENs: ‘The Times they are a Changin’ (2021) (2)
Recent advances in the localization and surgical management of duodenal gastrinomas. (1994) (2)
Connective tissue growth factor is over-expressed in ileal carcinoids (2003) (2)
Blood neuroendocrine tumor gene cluster analysis to predict somatostatin analog response. (2016) (2)
A multi-transcript blood signature for detection and assessment of gut neuroendocrine tumors. (2014) (2)
373 Regulation of Small Intestinal EC Cell Serotonin Release - the Role of Taste and Mechanical Forces (2008) (2)
Circulating biomarkers of gastroenteropancreatic and lung neuroendocrine neoplasms: “The times they are a changin” (2021) (2)
Gastrin-mediated alterations in gastric epithelial apoptosis and proliferation in a rodent model of gastric neoplasia (1998) (2)
Multiple endocrine neoplasia: Part I. Wermer's syndrome. (1979) (2)
George Sachs-"I did it my way". (2006) (2)
Nikolai Konstantinovich Kulchitsky (1856–1925) (2009) (2)
Adenosine A2 receptor signalling mediates chromogranin A secretion from neuroendocrine Tumours (2009) (2)
A metastatic tumor is no different to a viral pandemic: lessons learnt from COVID-19 may teach us to change the PRRT paradigm (2020) (2)
Cell and tumour biology of the gastric enterochromaffin-like cell. (1999) (2)
reference genes for real-time PCR GeneChip, geNorm, and gastrointestinal tumors: novel (2015) (2)
Clinical diagnostic utility of a blood-based multi-transcriptome assay for gastroenteropancreatic disease. (2015) (2)
The diagnosis and management of gastrinoma. (1984) (2)
The Path to the Future: Education of Nuclear Medicine Therapeutic Specialists as Responsible Physicians (2019) (2)
The utility of blood-based molecular tools-the NETest-to monitor and evaluate the efficacy of PRRT in neuroendocrine tumors. (2020) (1)
The TGF beta-1 signaling pathway, mitogenic and fibrotic pathways in ileal carcinoids (2003) (1)
[Efficacy and safety of intravenously administered pantoprazole in the treatment of gastrinoma]. (2001) (1)
Helicobacter pylori lipopolysaccharide (LPS) stimulated enterochromaffin-like (ECL) cell mitogenesis is modulated in part by a novel CD14 receptor mediated polyamine pathway (1998) (1)
[Influence of Helicobacter pylori lipopolysaccharide on the function of enterochromaffin-like cells in vitro]. (1999) (1)
A polyamine pathway-mediated mitogenic mechanism in enterochromaffin-like cells of Mastomys. (1998) (1)
Diagnostic Applications of Nuclear Medicine: Neuroendocrine Tumors (2016) (1)
MiR196a Plays a Critical Role in Regulating Small Intestinal Neuroendocrine Tumor Proliferation and Metastasis via HOX/AKT Pathway Activation (2011) (1)
geNorm assessment of the efficacy of novel reference genes ALG9, TFCP2 and ZNF410 compared to GAPDH for real time normalization in GI carcinoids. (2006) (1)
The failure of clinical factors to predict long-term toxicity after PRRT in >800 patients - Is a genetic screen needed? (2014) (1)
A gastric sexology: the story of three men and three bottles of gastric juice. (1999) (1)
A New Look at an Old Hormone (1993) (1)
A blood-based multi-mRNA liquid biopsy with >90% accuracy for diagnosis and assessment of prostate cancers. (2020) (1)
The effect of Helicobacter pylori on enterochromaffin-like (ECL) cell function (1998) (1)
Erratum to: Molecular mechanisms in therapy of acid-related diseases (2011) (1)
Comparison of PCR-based detection of chromogranin A mRNA with traditional histological lymph node staging of small intestinal neuroendocrine neoplasia (2012) (1)
The Surgical Legacy of Arris and Gale (1996) (1)
Blood transcript analysis and metastatic recurrent small bowel carcinoid management (2014) (1)
The NERD Task Force: Overview and Consensus: Vevey, November-December 2007 (2008) (1)
Mo1560 Impaired Autophagy in Gastric Carcinoids and Adenocarcinoma of Both Rodent Models and Patients (2012) (1)
Somatostatin Analogue Therapy (2008) (1)
595 The Role of Luminal Tastants and Olfactants in the Regulation of Gut Neuroendocrine Cell Secretion and the Implications for Gastrointestinal Health and Disease (2009) (1)
Gene network-based analysis identifies two potential subtypes of small intestinal neuroendocrine tumors (2014) (1)
Blood measurements of neuroendocrine tumor (NET) transcripts and gene cluster analysis to predict efficacy of peptide radioreceptor therapy. (2017) (1)
Peptide receptor radionuclide therapy (PRRT) transcriptomic signature in blood for prediction of 177lu-octreotate efficacy. (2018) (1)
M1713 Mechanisms of Crosstalk Between Intestinal EC and L Cells: the Roles of Serotonin and Glucagon-Like Peptide 1 in Regulating Neuroendocrine Cell Function (2010) (1)
Neuroendocrine Tumors: Therapy with Radiolabeled Peptides (2016) (1)
Alteration of DNA methylation status induced by epidermal growth factor in gastric cancer cell line, MKN-74. (2003) (1)
The Influence of Theodor Kocher on American Surgeons (1997) (1)
31 The Role of Gastrointestinal Mechanical Forces in the Regulation of Gut Enterochromaffin Cell Secretion and the Implications for Irritable Bowel Disease (2009) (1)
Abolition of ECL cell tumor DNA synthesis by DFMO A critical role for polyamines (1997) (1)
A GEP-NEN analysis of incidence, ethic variation, and mortality using the SEER database. (2012) (1)
Effect of pan-inhibitory somatostatin analogues, topotecan and bortezomib on the human enterochromaffin neoplastic cell line KRJ-I. (2006) (1)
Foreword (2019) (0)
A multi-gene colorectal cancer liquid biopsy with >90% accuracy in diagnosis and assessment of disease status. (2020) (0)
Amsterdam and Netherlands gastroenterology: a historical perspective. (2002) (0)
PRRT neuroendocrine tumor response assessment using blood transcript analysis: The NETest. (2020) (0)
761 Circulating Neuroendocrine Gene Transcripts Accurately Identify GEP-NETs, Are Decreased by Surgery and Predict Tumor Progression and Recurrence (2016) (0)
Subject Index Vol. 62, 2000 (2000) (0)
Subject Index, Vol. 54, Supplement 1, 1993 (1993) (0)
Abstract 1789: A gene expression-based nomogram predicts overall and progression free survival in PRRT-treated gastroenteropancreatic neuroendocrine tumors (2017) (0)
A predictive quotient index, comprising neuroendocrine gene cluster analysis in blood and tissue grading is specifically predicts PRRT efficacy (2017) (0)
T1718 SNP Identification of Common Gene Alterations in Crohn's Disease and Familial Neuroendocrine Tumors: Concordant Expression of Immune-Associated Genes (2010) (0)
Surgery of the stomach and duodenum. Fourth ed: Edited by Lloyd M. Nyhus and Christopher Wastell. 914 pp., $95.00. Little, Brown, and Company, Boston, Massachusetts, 1986. ISBN 0-316-61740-7 (1987) (0)
Advances in Gastrointestinal Surgery (1986) (0)
Genomic analysis of human gastric ECL cell carcinoid tumors (2003) (0)
Automated finger prick genomic diagnosis of neuroendocrine tumors (2018) (0)
Adenosine receptors modulate chromogranin A secretion and growth of neuroendocrine tumours: potential targets for therapy (2011) (0)
Tumor suppressor gene methylation and expression during gastric neuroendocrine-ecl cell transformation (2000) (0)
Gastric Neuroendocrine Neoplasia (2009) (0)
A GEP NETs B Cancers Rectum Small intestine Stomach Colon Pancreas Rectum Small intestine Stomach Colon Pancreas Liver All GEP NETs Survival (2013) (0)
Intestinal serotonin (5-HT) signalling is hormonally regulated via glucagon-like peptide 1 (GLP1) and PKA/MAPK activation (2010) (0)
Telenzepine defines the differential role of parietal and enterochromaffin-like (ECL) cell muscarinic receptors in gastric secretory functions (1998) (0)
A comparison of the changes in gastric and duodenal mucosal concentrations of TGFα in duodenal ulcer patients treated with sucralfate and ranitidine (1995) (0)
A 13-gene colorectal cancer liquid biopsy with greater than 90 percent accuracy in diagnosis and assessment of disease status. (2020) (0)
Acknowledgement to Referees (1998) (0)
Perspectives and reflections on integrated digestive surgery. (2002) (0)
A liquid biopsy for the diagnosis and monitoring of bronchopulmonary/lung carcinoid (2017) (0)
Alterations of somatostatin and its type-2 receptor expression in the gastric mucosa of mastomys during the development of carcinoid tumors (1998) (0)
Induction and reversal of gastric endocrine cell proliferation during histamine2-receptor blockade (1992) (0)
Contents Vol. 100, 2014 (2015) (0)
Subject Index Vol. 83, 2006 (2006) (0)
556 A Mechanistic Role for the Chromatin Modulator, NAP1L1, in Pancreatic Neuroendocrine Neoplasm Metastasis (2012) (0)
From the pump to the helix (2000) (0)
Diagnostic, Clinical, and Therapeutic Aspects of Gastric Carcinoids (1997) (0)
Abstract LB-061: Systematic, network-based, comparative analysis of differential mechanisms of action of lanreotide and octreotide in neuroendocrine tumor derived cell lines (2018) (0)
The Role of Serotonin and the 5HT7 Receptor in IGF-I Synthesis and Secretion in the “Carcinoid” Tumor: Hepatocyte Microenvironment (2011) (0)
The concept of the ‘carcinoid’: The phylogenic and ontogenic evolution of the unresolved karzinoide conundrum (2021) (0)
Surgery of the stomach and duodenum. Fourth ed (1987) (0)
Contents Vol. 89, 2009 (2009) (0)
Isolation and evaluation of the rat ileal enterochromaffin (EC) cell biology (2003) (0)
38 the pump to the helix (2000) (0)
Circulating Neuroendocrine Gene Signature is Concordant with Pancreatic Neuroendocrine Tumor Transcriptomes and Predicts Disease Progression (2017) (0)
Nordic and North American neuro endocrine tumor management : A clinical and scientific synopsis (2008) (0)
OMIC gene cluster evaluation amplifies the prognostic accuracy of the NETest (2020) (0)
Ultrastructral Evidence for a Mechanism of ECL Cell Transformation to Gastric Carcinoid in Mastomys Involving Impairment of Autophagy and Loss of Gastrin Control (2011) (0)
Post-operative NETest scores detect residual NET disease and accurately predicts tumor recurrence in R0 (2020) (0)
Circulating neuroendocrine tumor gene expression is effective in monitoring peptide receptor radionuclide (PRRT) efficacy (2018) (0)
Chromogranin A fragments, vasostatin and chromostatin, are regulatory peptides that control small intestinal neuroendocrine tumour proliferation via AKT/mTOR signalling (2010) (0)
Contents Vol. 62, 2000 (2000) (0)
The NERD Task Force: Overview and Consensus (2016) (0)
Sa1825 The Clinical Utility of Blood Derived Gene Cluster Analysis of Neuroendocrine Tumors Using Neoplasia Hallmark Criteria (2015) (0)
Inefficacy of chromogranin a assays as neuroendocrine tumor diagnostic tools compared to the NETest. (2020) (0)
1063 Expression of the Transcription Factor TBX2 is Significantly Associated With Proliferation of Gastroenteropancreatic Neuroendocrine Neoplasm and Represents a Novel Candidate Prognostic Marker (2012) (0)
Circulating Neuroendocrine Tumor (NET) Transcripts are Detectable in Pancreatic Neuroendocrine Tumor Tissue (PNET) Transcriptomes and Provide a Molecular Basis to Classify Disease Progression (2017) (0)
Neuroendocrine gene transcript analysis of blood to define the completeness of surgical resection and identify stable or progressive neuroendocrine tumor disease. (2015) (0)
Changing trends in gender, race, and site-specific gastrointestinal carcinoid tumor incidence: The latest word (2003) (0)
Contents, Vol. 14, 1997 (1997) (0)
New PharmacologicTherapies for Gastroenteropancreatic Neuroendocrine Tumors (2010) (0)
A genomic blood test (NETest) identifies neuroendocrine transformation of prostate cancer. (2020) (0)
Foreword (1997) (0)
Abstract 3389: A multi-gene prostate cancer liquid biopsy with > 92% accuracy in diagnosis and assessment of disease status (2020) (0)
F-032BLOOD MEASUREMENT OF NEUROENDOCRINE GENE TRANSCRIPTS IS DIAGNOSTIC FOR BRONCHOPULMONARY CARCINOID AND IDENTIFIES THE EFFECTIVENESS OF SURGICAL RESECTION (2017) (0)
Multi-parametric assessment improves prognostication of small bowel neuroendocrine neoplasms: external validation of the NET nomogram (2017) (0)
325 Factors Influencing the Development of Toxicity After Peptide Radio-Receptor Therapy for NETs: an Evaluation of 807 Patients (2014) (0)
Neoplastic lesions of endocrine cells in the gastrointestinal tract: ten evolving principles as a basis for clinical understanding (2012) (0)
Gastroenteropancreatic and Bronchopulmonary Neuroendocrine Neoplasms, Genetics of (2013) (0)
A multianalyte algorithm PCR-based gene blood test compared to single analyte ELISA-based blood tests for neuroendocrine tumor detection. (2014) (0)
Surgery in combination with peptide receptor radionuclide therapy is effective in metastatic neuroendocrine tumors and is definable by blood gene transcript analysis. (2017) (0)
Abstract 3106: A blood-based neuroendocrine tumor multi-transcript test predicts and defines PRRT efficacy in neuroendocrine tumors (2016) (0)
Prognostication by multigene proliferative marker panel compared with Ki-67 in small-intestinal NENs. (2012) (0)
Carcinoid Syndrome (1980) (0)
Serotonin is a critical signalling molecule in the local and metastatic small intestinal neuroendocrine tumour microenvironment (2010) (0)
transformation pathway induced by gastrin-mediated gastric mucosa identifies alterations in the natalensis Mastomys Global expression analysis of ECL cells in (2014) (0)
A meta-analysis of the accuracy of a neuroendocrine tumor mRNA biomarker (NETest) in the blood. (2020) (0)
Abstract 1999: Diagnostic utility of the NETest in neuroendocrine transformed prostate cancer (2020) (0)
M1730 The Chromogranin a Peptides, Vasostatin and Chromostatin, Differentially Regulate Small Intestinal Neuroendocrine Tumor Proliferation Through the AKT/mTOR Pathway (2010) (0)
44 High Efficacy of Gene Expression Profiling and Regularized Discriminant Analysis in the Prediction of Neuroendocrine Tumor Subtypes and Their Metastases (2009) (0)
Clinical endocrinology and metabolism: The gut as an endocrine organ (1994) (0)
324 A Multi-Transcript Blood Signature Outperforms Chromogranin a for Detecting Gut Neuroendocrine Tumors (2014) (0)
Blood-Based Neuroendocrine Tumor mRNA Signature Identifies Residual Disease and at Day 30 after Operation Predicts Tumor Recurrence with 98% Specificity (2020) (0)
A PCR-Based Multigene Transcript Analysis Blood Test Outperforms Chromogranin A in the Detection of Gastrointestinal and Pancreatic Neuroendocrine Tumors and Is Unaffected by PPI Use or Hypertension (2014) (0)
Blood measurements of Neuroendocrine Tumor (NET) transcripts and gene cluster analysis predict efficacy of PRRT (2017) (0)
Telenzepine-sensitive muscarinic receptors on rat pancreatic acinar cells. (1998) (0)
Subject Index, Vol. 10, Supplement 1, 1992 (1992) (0)
Insulinomas do pancreas (1981) (0)
Subject Index Vol. 11, 1994 (1994) (0)
Contents Vol. 83, 2006 (2006) (0)
The mechanism of the inhibitory effect of cyclin D1 antisense (AS/D1) on EGF stimulated proliferation of the human gastric cancer cell line, MKN-74 cell (2000) (0)
SESSION VI: INNOVATIVE/EXPERIMENTAL F-032 BLOOD MEASUREMENT OF NEUROENDOCRINE GENE TRANSCRIPTS IS DIAGNOSTIC FOR BRONCHOPULMONARY CARCINOID AND IDENTIFIES THE EFFECTIVENESS OF SURGICAL RESECTION GROUND-GLASS OPACITIES TAPING IMPROVES RECOVERY OF VENTILATORY FUNCTION AFTER THORACOTOMY LOBECTOMY FOR L (2017) (0)
Subject Index Vol. 14, 1997 (1997) (0)
Circulating neuroendocrine transcripts and gene cluster analysis to predict the efficacy of peptide radioreceptor therapy. (2016) (0)
Neuroendocrine Gene Transcripts: The Role of Molecular Biomarkers in Diagnosis and Management (2018) (0)
Prediction of early prostate cancer recurrence using a liquid biopsy approach. (2023) (0)
Current Status of Gastroenteropancreatic Tumor Management (2002) (0)
ENETS Newsletter Summer/Fall 2013 (2013) (0)
Hypoxia, Adenosine, and Adenosine Receptor 2B as Pathophysiological Regulators of Gut Enterochromaffin Cell Serotonin Synthesis and Secretion in Active Crohn's Disease (2011) (0)
Clinical utility of blood derived gene cluster analysis of neuroendocrine tumors using neoplasia hallmark criteria. (2015) (0)
A precision oncology approach to the pharmacological targeting of mechanistic dependencies in neuroendocrine tumors (2018) (0)
Development and validation of a multigenomic liquid biopsy (PROSTest) for prostate cancer detection. (2023) (0)
454PComparison of clinical efficacy of SST analogues therapy (lanreotide autogel vs. octreotide LAR) in treatment of patients with advance, non-resectable pancreatic neuroendocrine tumours (pNETs) (2017) (0)
Endocrine-Related Cancer ( 2012 ) 19 R 163 – R 185 Neuroendocrine tumor disease : an evolving landscape (2012) (0)
What Is the Role and Priority of Diagnostic Tests ( Endoscopy With or Without Biopsy , Esophageal Manometry , Ambulatory pH Monitoring , Impedance-pH Monitoring ) in the Evaluation of Patients With Suspected Esophageal GERD Syndromes ? (2008) (0)
Multiple endocrine neoplasia: Part II. Sipple's syndrome. (1979) (0)
Signaling pathways in neuroendocrine tumors (2011) (0)
Validation of a blood biomarker test for the diagnosis and management of bronchopulmonary neuroendocrine tumors (2017) (0)
The Molecular Biology of NET: Current Status and Evaluation of Biomarkers for Prediction and Prognosis (2018) (0)
44 Abnormal Immune-Mediated (IL1β/LPS) Regulation of Small Intestinal EC Cell Serotonin Release in Inflammatory Bowel Disease (2008) (0)
Clinical endocrinology and metabolism: The gut as an endocrine organ: Edited by P. Fuller and A. Shulkes. 236 pp. $27.50. Harcourt Brace & Company, Kent, England, 1994. ISBN 0-7020-1817-1 (1994) (0)
217 The Role of Umami and Glutamate Receptors in the Gastrin-EC Cell Axis and the Implications of a Serotonin-Gastrin Interface in the Regulation of Acid Secretion (2010) (0)
134 Interactions Between Hepatocytes and Neuroendocrine Tumor Cells: the Role of Serotonin and the 5HT2B Receptor in Hepatocyte Function (2010) (0)
Author lndex Vol. 14, 1997 (1997) (0)
Sa1826 Neuroendocrine Gene Transcript Analysis of Blood Identifies Stable or Progressive NET Disease Treated With Somatostatin Analogs (2015) (0)
A mechanistic role for the chromatin modulator, NAP1L1, in pancreatic neuroendocrine neoplasm proliferation and metastases (2014) (0)
Subject Index Vol. 89, 2009 (2009) (0)
Evaluation of a novel transcriptomic tumor signature (PROSTest) as response biomarker for 177Lu-PSMA therapy in advanced prostate cancer. (2023) (0)
The DNA stimulatory effect of Helicobacter pylori lipopolysaccharide is related to the clinical virulence fingerprint of gastric cancer isolates (2001) (0)
Role Of Hypoxia And Adenosine In Regulating Enterochromaffin (EC) Cell Serotonin (5HT) Secretion In Crohn's Disease (CD) (2011) (0)
Multiple gastric carcinoids. (2004) (0)
Subject Index Vol. 13, 1997 (1997) (0)
Peptide radio receptor therapy: The huff and puff strategy of neuroendocrine disease management (2021) (0)
341 Neuroendocrine Tumor Blood Transcript Analysis, the NETest, Predicts Gastroenteropancreatic Neuroendocrine Tumor Disease Status and Is Prognostic for Progressive Disease (2016) (0)
List of available training programs. (1989) (0)
Abstract 3115: Translational clinical utility of a circulating neuroendocrine tumor transcript measurement (2016) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Irvin Mark Modlin?

Irvin Mark Modlin is affiliated with the following schools: